Us News

Weighing the risks and benefits of GLP-1 drugs for kids struggling with obesity

Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more.

Published June 23, 2026, 1:31 PM
Updated June 23, 2026, 2:25 PM1.9K
Share𝕏f
Weighing the risks and benefits of GLP-1 drugs for kids struggling with obesity

Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more.

Share𝕏f
News17 is committed to delivering accurate, fair, and thoroughly researched reporting. If you believe this article contains an error, please contact our editorial team at corrections@news17.net. We take all reports seriously and will issue corrections promptly when warranted.